Investors

ReGen Biologics is an orthopedic products company that develops, manufactures and markets innovative tissue repair products for U.S. and global markets. ReGen's patented collagen scaffold technology includes applications in orthopedics, general surgery, spine, cardiovascular and drug delivery.  The Company’s first approved product using its collagen scaffold technology is Menaflex™ collagen meniscus implant (formerly CMI^®).

ReGen is headquartered in Hackensack, NJ and manufactures its collagen scaffold products in its ISO Certified facility located in Redwood City, CA.